Kinetics of [methyl-¹¹ C]Thymidine in Patients with Squamous Cell Carcinoma of the Head and Neck

References

• Begg A, Hofland I, Moonen L, et al. The predictive value of cell kinetics measurements in a European trial of accelerated fractionation in advanced head and neck tumours: an interim report. Int J Radiat Oncol Biol Phys 1990; 19: 1449–53
   PubMed Web of Science ®Google Scholar
• Bourhis J, Wilson G, Wilbault P, et al. In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys 1993; 26: 793–9
   PubMedGoogle Scholar
• Dische S, Saunders M I. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Editorial. Br J Cancer 1989; 59: 325–6
   PubMedGoogle Scholar
• Molinari R, Costa A, Veneroni S, Matavelli F, Salvatori, Silvestrini P. R. Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumours. J. Oral Pathol Med 1991; 20: 32–6
   PubMedGoogle Scholar
• Fowler J F. Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer. Int J Radiat Oncol Biol Phys 1991; 21: 1451–6
   PubMed Web of Science ®Google Scholar
• Martiat Ph, Ferrant A, Labar D, et al. In vivo measurement of carbon-11 thymidine uptake in non-hodgkin's lymphoma using positron emission tomography. J Nucl Med 1988; 29: 1633–7
   PubMed Web of Science ®Google Scholar
• van Eijkeren M, De Schryver A, Goethals P, et al. Measurement of short-term 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET). Acta Oncol 1992; 31: 539–43
   PubMed Web of Science ®Google Scholar
• Goethals P, Sambre J, Coene M, Casteleyn K, Poupeye E. A remotely controlled production system for routine preparation of [methyl-11 C]thymidine. Appl Radiat Isot 1992; 7: 952–4
   Google Scholar
• Meyer G.-J, Coenen H H, Waters S L, . Quality assurance and quality control of short-lived radiopharmaceuticals for PET. Radiopharmaceuticals for positron emission tomography. Methodological aspects. Developments in Nuclear Medicine, G Stöcklin, V W Pike, et al. Kluwer Academic Publishers, Dordrecht 1993; vol. 24: 91–150
   Google Scholar
• Desmedt P, Lemahieu I, Bastiaens K. Statistical image reconstruction techniques in positron emission tomography. Communication and integration in healthcare informatics M.I.C. 93, G De Moor. ACCO, Leuven 1993; 137–48
   Google Scholar
• Goethals P, van Eijkeren M, Lodewijkx W, Dams R. Measurement of [methyl-11Cjthymidine and its 11C-metabolites in blood of patients with head and neck tumours. J Nucl Med 1995; 36: 880–2
   PubMedGoogle Scholar
• Leskinen-Kallio S, Någren K, Lehikoinen P, Ruotsalainer U, Teras M, Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992; 33: 691–5
   PubMed Web of Science ®Google Scholar
• Kubota K, Yamada S, Ishiwata K, et al. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study. Eur J Nucl Med 1993; 20: 495–501
   PubMedGoogle Scholar
• Strauss L G, Conti P S. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623–48
   PubMed Web of Science ®Google Scholar
• Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis. J Nucl Med 1991; 32: 686–91
   PubMed Web of Science ®Google Scholar
• Haberkorn U, Strauss L G, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34: 12–7
   PubMed Web of Science ®Google Scholar
• Adams R LP. The effect of endogenous pools of thymidylate on the apparent rate of DNA synthesis. Exp Cell Res 1969; 56: 55–8
   PubMedGoogle Scholar
• Holden L, Hoffbrand A V, Tattersall M HN. Thymidine concentrations in human sera: variations in patients with leukemia and megaloblastic anaemia. Eur J Cancer 1980; 16: 115–21
   PubMed Web of Science ®Google Scholar
• Shields A F, Coonrod D V, Quackenbush R C, Crowley J J. Cellular sources of thymidine nucleotides: studies for PET. J Nucl Med 1987; 28: 1435–40
   PubMedGoogle Scholar
• Vanderborght T, Labar D, Pauwels S, Lambotte L. Production of [2-11C]thymidine for quantification of cellular proliferation with PET. Int J Appl Radiat Isot 1991; 41: 103–4
   Google Scholar
• Raichle M E, Grubb R L, Higgins C S. Measurement of brain tissue carbon dioxide content in vivo by emission tomography. Brain Res 1979; 166: 413–7
   PubMedGoogle Scholar
• Vanderborght T, De Maeght S, Labar D, Goethals P, van Eijkeren M, Pauwels S. Comparison of thymidine labelled in the methyl group and in 2C-ring position in human PET studies. Eur J Nucl Med 1992; 19: 578, (Abstract)
   Google Scholar
• Goethals P, Lameire N, van Eijkeren M, Thierens H, Dams R. Evaluation of [methyl-11 C]thymidine for in vivo measuring cell proliferation. J Nucl Med, in press
   Google Scholar